Featured news in The Life Sciences Report



Celgene Corp. (CELG:NASDAQ)
Celgene (CELG) Q4 Earnings: Will the Stock Pull a Surprise? (1/20/2017)

view
 

Celgene Corp. (CELG:NASDAQ)
Blog Coverage PharmAthene and Altimmune Announced a Merger; Set to Establish Immunotherapeutic Collaboration (1/20/2017)

view
 


MiMedx Group Inc. (MDXG:NASDAQ)
Lifshitz & Miller Law Firm Announces Investigation of Ally Financial Inc., Amphastar Pharmaceuticals, Inc., Lannett Company, Inc., Live Ventures Incorporated, MiMedx Group, Inc., Seattle Genetics, Inc., Teligent, Inc., TerraVia Holdings, Inc., and Zimmer (1/19/2017)

view
 


Sunesis Pharmaceuticals Inc. (SNSS:NASDAQ)
Synergy (SGYP) Trulance Wins FDA Approval for Constipation (1/20/2017)

view
 

Sunesis Pharmaceuticals Inc. (SNSS:NASDAQ)
Mallinckrodt to Pay $100M Fine to FTC for Questcor Matter (1/19/2017)

view
 

Sunesis Pharmaceuticals Inc. (SNSS:NASDAQ)
Aduro (ADRO) Inks License Agreement with Stanford University (1/20/2017)

view
 


Caladrius Biosciences Inc. (CLBS:NASDAQ)
Caladrius Biosciences Inc. (CLBS) Gives Up 3.32% at Midday on January 18, Pressuring Health Care Stocks (1/18/2017)

view
 


RXi Pharmaceuticals Corp. (PHIO:NASDAQ)
Health Care Sector Feels Weight of 4.92% Slide in Early Trading of RXi Pharmaceuticals Corporation (RXII) on January 18 (1/18/2017)

view
 

RXi Pharmaceuticals Corp. (PHIO:NASDAQ)
RXi Pharmaceuticals Corporation (RXII) Gives Up 4.78% at Midday on January 18, Pressuring Health Care Stocks (1/18/2017)

view
 


Regeneus Ltd. (RGS:ASX)
Announces Q4/16 News Update (1/17/2017)

view
 


Athersys Inc. ()
Athersys Subsidiary and Leading Animal Health Company Enter Into Research and Option Agreement for Cell Therapy (1/18/2017)

view
 


Celgene Corp. (CELG:NASDAQ)
4 Top Biotech Mutual Funds for 2017 (1/18/2017)

view
 


Sunesis Pharmaceuticals Inc. (SNSS:NASDAQ)
Kura Oncology Starts Dosing Patients in Phase II CMML Study (1/18/2017)

view